Tag: risk

The phrase “Walk to Earn?” has been trending across social platforms—not because people believe walking literally generates income, but because it reflects a broader desire for financial participation that feels simple, intuitive, and effortless.

DUBAI, United Arab Emirates, June 21, 2026 (GLOBE NEWSWIRE) --

Pepeto crossed $10.29 million in presale today, and every reading around this new crypto listing is forming a pattern the market has only seen twice before, with Dogecoin and Shiba Inu, both right ahead of the cycles that turned them into global names, while the project also rolled out a swap security update that pulls AI risk checks directly inside the trading layer.

DUBAI, United Arab Emirates, June 20, 2026 (GLOBE NEWSWIRE) --

Pepeto moved into final preparation ahead of a major exchange listing, and the presale became the fastest closing raise of 2026 as rounds close inside days, because $10.29 million is raised, 170% APY staking runs live, three products are in production, and wallets are pouring in at a pace that tells the reader the sharpest capital has already locked the entry before the listing pulls the price out of reach forever.

As BlackRock’s new Bitcoin income ETF draws global attention, AIXAlpha’s AI‑Powered Automated BTC Strategy Contracts offer a faster, daily‑settled alternative—no installation, no manual trading, no experience required.

New users receive a $99 free trial credit and a $7 instant cash bonus to experience live AI crypto trading bots with no coding, no setup, and no deposit required

마이애미, June 20, 2026 (GLOBE NEWSWIRE) --

, June 19, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs가 유럽 최초의 메모리 반도체 ETF인 Defiance Memory UCITS ETF(티커: DRAM)를 출시했다고 발표했다. 이 펀드는 메모리 반도체 및 데이터 저장 시스템의 개발, 제조, 상용화, 저장 기술과 관련된 기업들에 투자 기회를 제공하는 것을 목표로 한다.

TORONTO, June 19, 2026 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (“BlackRock”) (NYSE:BLK), today announced updated investment risk ratings of the iShares ETFs listed below, effective as of June 19, 2026:

New investor signal-intelligence platform reads social, forum, and news chatter across thousands of conversations — and surfaces the tickers the crowd is piling into, with the sentiment and catalysts behind them. Free to start.

SAN CARLOS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on June 18, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 140,860 shares of Iovance’s common stock to twenty-seven new, non-executive employees.